Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trial

• Andreas Kjær,
• Peter Rossing,
• Emilie H Zobel,
• Asger Wretlind,
• Rasmus S Ripa,
• Viktor Rotbain Curovic,
• Bernt J von Scholten,
• Tommi Suvitaival,
• Tine W Hansen,
• Cristina Legido-Quigley

Affiliations

Andreas Kjær

3 Department of Clinical Physiology, Nuclear Medicine & PET 4011, Cluster of Molecular Imaging, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

Peter Rossing

9 Steno Diabetes Center AS, Gentofte, Denmark

Emilie H Zobel

Steno Diabetes Center Copenhagen, Gentofte, Denmark

Asger Wretlind

Steno Diabetes Center Copenhagen, Gentofte, Denmark

Rasmus S Ripa

Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet, Copenhagen, Denmark

Viktor Rotbain Curovic

Steno Diabetes Center Copenhagen, Gentofte, Denmark

Bernt J von Scholten

Steno Diabetes Center Copenhagen, Gentofte, Denmark

Tommi Suvitaival

Steno Diabetes Center Copenhagen, Gentofte, Denmark

Tine W Hansen

Steno Diabetes Center Copenhagen, Gentofte, Denmark

Cristina Legido-Quigley

Steno Diabetes Center Copenhagen, Gentofte, Denmark